Pediatrix Medical (MD) Non-Current Deferred Tax Liability (2016 - 2025)
Pediatrix Medical (MD) has disclosed Non-Current Deferred Tax Liability for 17 consecutive years, with $38.3 million as the latest value for Q3 2025.
- On a quarterly basis, Non-Current Deferred Tax Liability rose 7.49% to $38.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $38.3 million, a 7.49% increase, with the full-year FY2024 number at $34.2 million, changed 0.18% from a year prior.
- Non-Current Deferred Tax Liability was $38.3 million for Q3 2025 at Pediatrix Medical, up from $36.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $61.7 million in Q1 2021 to a low of $30.6 million in Q2 2024.
- A 5-year average of $39.3 million and a median of $37.8 million in 2023 define the central range for Non-Current Deferred Tax Liability.
- Peak YoY movement for Non-Current Deferred Tax Liability: crashed 36.35% in 2022, then grew 17.61% in 2025.
- Pediatrix Medical's Non-Current Deferred Tax Liability stood at $41.4 million in 2021, then fell by 18.77% to $33.6 million in 2022, then increased by 1.99% to $34.3 million in 2023, then decreased by 0.18% to $34.2 million in 2024, then grew by 11.79% to $38.3 million in 2025.
- Per Business Quant, the three most recent readings for MD's Non-Current Deferred Tax Liability are $38.3 million (Q3 2025), $36.0 million (Q2 2025), and $34.4 million (Q1 2025).